{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:59Z","timestamp":1786118639201,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To demonstrate the response of a juxtapapillary retinal hemangioblastoma (JRH) to belzutifan in a patient with Von-Hippel\u2013Lindau syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This case report includes fundus photography and optical coherence tomography to compare a JRH before and 24 months after treatment with belzutifan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>An 18-year-old woman with Von-Hippel\u2013Lindau syndrome was diagnosed with a JRH at age 13. The retinal lesion progressively worsened over 5 years and required two sessions of laser therapy with minimal improvement but loss of visual field. She was treated with the oral HIF2a-inhibitor, belzutifan, with minimal side effects. At 24 months of therapy, her JRH has decreased in height from 1,258 \u03bcm to 874 \u03bcm and width from 4,448 \u03bcm to 3,786 \u03bcm and vision is 20\/20.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Belzutifan demonstrates impressive clinical activity in Von-Hippel\u2013Lindau syndrome\u2013associated JRH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/icb.0000000000001606","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:00:10Z","timestamp":1716559210000},"page":"544-547","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["RESPONSE OF A VON HIPPEL\u2013LINDAU\u2013ASSOCIATED OPTIC NERVE HEMANGIOBLASTOMA TO BELZUTIFAN"],"prefix":"10.1097","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-1820","authenticated-orcid":false,"given":"Julia","family":"Meade","sequence":"first","affiliation":[{"name":"Division of Pediatric Oncology\/Hematology, University of Pittsburgh School of Medicine, Pittsburgh, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal","family":"Nischal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl R.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Retina Vitreous Consultants, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250627","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0161-6420(00)00422-X","article-title":"Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes","volume":"107","author":"McCabe","year":"2000","journal-title":"Ophthalmology"},{"key":"R2-20250627","doi-asserted-by":"crossref","first-page":"244077","DOI":"10.1136\/bcr-2021-244077","article-title":"Isolated juxtapapillary retinal capillary haemangioblastoma and exudative maculopathy in an elderly patient without von Hippel-Lindau syndrome: combined proton beam radiotherapy and intravitreal anti-VEGF","volume":"14","author":"Adan","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R3-20250627","first-page":"542","article-title":"Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome","volume":"27","author":"Murro","year":"2021","journal-title":"Mol Vis"},{"key":"R4-20250627","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"key":"R5-20250627","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R6-20250627","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.4103\/ijo.IJO_1799_18","article-title":"Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma","volume":"67","author":"Ucan Gunduz","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R7-20250627","first-page":"521","article-title":"Photocoagulation for juxtapapillary retinal hemangioma in a young girl: a case report","volume":"10","author":"Kase","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"R8-20250627","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","article-title":"Management of retinal hemangioblastoma in von-Hippel-Lindau disease","volume":"39","author":"Wiley","year":"2019","journal-title":"Retina"},{"key":"R9-20250627","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4103\/ijo.IJO_1081_19","article-title":"Safety of photodynamic therapy involving optic nerve head","volume":"68","author":"Manayath","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R10-20250627","first-page":"756840","article-title":"Photodynamic therapy for juxtapapillary retinal capillary hemangioma","volume":"2014","author":"Mitropoulos","year":"2014","journal-title":"Case Rep Ophthalmol Med"},{"key":"R11-20250627","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1755-3768.2010.02008.x","article-title":"Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma","volume":"88","author":"Sachdeva","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R12-20250627","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1442-9071.2005.01071.x","article-title":"Photodynamic therapy in the management of juxtapapillary capillary haemangiomas","volume":"33","author":"Golshevsky","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"R13-20250627","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","article-title":"Treatment of retinal capillary hemangioma","volume":"109","author":"Singh","year":"2002","journal-title":"Ophthalmology"},{"key":"R14-20250627","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10792-016-0183-x","article-title":"Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma","volume":"36","author":"Agarwal","year":"2016","journal-title":"Int Ophthalmol"},{"key":"R15-20250627","article-title":"Successful treatment of von Hippel-Lindau (VHL) disease-associated retinal capillary hemangioblastoma (RCH) with belzutifan in a pediatric patient","author":"Jones","year":"2023","journal-title":"RETINAL Cases Brief Rep"},{"key":"R16-20250627","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","article-title":"Von-hippel Lindau disease","volume":"462","author":"Singh","year":"2001","journal-title":"Survey of Ophthalmology"},{"key":"R17-20250627","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/IAE.0000000000000254","article-title":"Therapeutic outcomes of retinal hemangioblastomas","volume":"34","author":"Kim","year":"2014","journal-title":"Retina"},{"key":"R18-20250627","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ophtha.2010.04.031","article-title":"Vitreoretinal surgery for severe retinal capillary hemangiomas in Von-Hippel-Lindau disease","volume":"118","author":"Gaudric","year":"2011","journal-title":"Ophthalmology"},{"key":"R19-20250627","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s40265-021-01606-x","article-title":"Belzutifan: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"R20-20250627","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ophtha.2022.07.007","article-title":"Systemic treatment reduces von-Hippel-Lindau associated retinal capillary hemangioblastoma","volume":"130","author":"Fairbanks","year":"2023","journal-title":"Ophthalmology"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICB.0000000000001606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:35:36Z","timestamp":1786034136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ICB.0000000000001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000001606","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}